Resgreen (Stock Symbol: RGGI) announces the sale of its Wanda SD to disinfect the Palm Beach Florida Sheriff's Office - Brazil Business Today
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Ted Cruz has raided campaign funds for travel "security" (but apparently not in Cancún)
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Posted on 8728
PMC Group International, Inc., which is an independent arm of PMC Group Companies, announced the acquisition of Cobra Investments Management Inc. and its two subsidiaries, Copperhead Chemical Company Inc. (“Copperhead”) and Copperhead Investments Inc., from a group of previous owners of these entities, effective February 5, 2021. Copperhead is the manufacturing arm of the three acquired entities and is located on an 875 acres facility with 53 buildings in Tamaqua, Pennsylvania.
Copperhead has been the sole manufacturer of the FDA approved cardiac therapeutic drug nitroglycerin in the US for over 70 years and a custom manufacturer of drug dosage forms. It is also a major producer of energetic chemicals (explosives and propellants) for the defense industry as well as a novel class of preservatives and antimicrobials. Copperhead’s products are sold globally.
Share this article
Share this article
WEST PALM BEACH, Fla., Feb. 17, 2021 /PRNewswire/ American Sugar Refining, Inc., a member of ASR Group, made a strategic investment in Bonumose, Inc. to produce and commercialize lower-cost, plant-based alternative sweeteners tagatose and allulose as part of ASR Group s strategy to provide a variety of products to meet the wide range of consumer needs.
The Series B investment round in Bonumose, a start-up company with innovations in plant-based food ingredients, was co-led by American Sugar Refining and The Hershey Company (NYSE: HSY).
Bonumose developed and patented a production process for high-purity rare sugars, including tagatose and allulose, from low-cost, abundant, plant-based starches. These products have fewer calories than traditional sugars and a negligible glycemic index impact.